CTRI/2020/04/024754
Completed
Phase 2
Study The Efficacy Of Topical Timolol In Chronic Recalcitrant Wounds
Dr Viral Chaitanya Bhatt0 sites100 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Dr Viral Chaitanya Bhatt
- Enrollment
- 100
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Any patient of chronic recalcitrant non healing wounds, between 30 to 60 years of age, of both sexes, are eligible for this study
Exclusion Criteria
- •Age less than 30 and more than 60
- •Pregnant females
- •Ischemic ulcers patient
- •Patients suffering from\- Copd, bradycardia disorders, bradyarrythmias, heart block, ccf, patient already on beta blockers
Investigators
Similar Trials
Recruiting
Phase 2
Evaluation of efficacy of Topical Timolol for treatment in conjunctival Pyogenic GranulomPyogenic granuloma.Pyogenic granulomaL98.0IRCT20160523028008N27Hamedan University of Medical Sciences46
Completed
Phase 3
Topical Timolol Effectiveness for prophylaxy of radiation induced dermatitis in breast cancer patientsRadiodermatitis.Malignant neoplasm of breastIRCT20190810044500N11Yazd University of Medical Sciences64
Completed
Phase 1
To determine effectiveness of topical application of 0.5% Timolol Maleate in treatment of chronic heel recalcitrant fissuresIRCT20230712058759N1Pak Emirates Military Hospital150
Recruiting
Phase 2
Treatment of Superficial Strawberry Birthmarks with Topical TimololInfantile HaemangiomaSkin - Dermatological conditionsACTRN12619001370190Gillies McIndoe Research Institute50
Withdrawn
Phase 4
Topical Timolol for the Treatment of Benign Vascular Periocular LesionsBenign Vascular Periocular LesionsNCT01250457Loyola University